Loading viewer...
investor_presentation
Format: PDF investor_presentation
Inotiv, Inc. is a contract research organization (CRO) providing comprehensive research science, models and services for biopharmaceutical discovery and development. Operating through Discovery and Safety Assessment and Research Models and Services segments, the company serves approximately 3,500 customers and employs over 2,100 people. Founded in 1974 and reinvented in 2017, Inotiv helps reduce time and cost in bringing new drugs to market.
investor_presentation
26 Pages
investor_presentation
38 Pages
TPG Inc.